ATE338043T1 - 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten - Google Patents
5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonistenInfo
- Publication number
- ATE338043T1 ATE338043T1 AT02777254T AT02777254T ATE338043T1 AT E338043 T1 ATE338043 T1 AT E338043T1 AT 02777254 T AT02777254 T AT 02777254T AT 02777254 T AT02777254 T AT 02777254T AT E338043 T1 ATE338043 T1 AT E338043T1
- Authority
- AT
- Austria
- Prior art keywords
- aöpyridine
- methoxy
- aryl
- derivatives
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01123949 | 2001-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE338043T1 true ATE338043T1 (de) | 2006-09-15 |
Family
ID=8178877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02777254T ATE338043T1 (de) | 2001-10-08 | 2002-09-28 | 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten |
Country Status (16)
Country | Link |
---|---|
US (1) | US6693116B2 (de) |
EP (1) | EP1436292B1 (de) |
JP (1) | JP4101756B2 (de) |
KR (1) | KR100604407B1 (de) |
CN (1) | CN1254475C (de) |
AR (1) | AR036735A1 (de) |
AT (1) | ATE338043T1 (de) |
AU (1) | AU2002338827B2 (de) |
BR (1) | BR0213177A (de) |
CA (1) | CA2462801A1 (de) |
DE (1) | DE60214408T2 (de) |
ES (1) | ES2269772T3 (de) |
MX (1) | MXPA04003278A (de) |
PL (1) | PL370565A1 (de) |
RU (1) | RU2298009C2 (de) |
WO (1) | WO2003031445A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830978B (zh) * | 2005-03-07 | 2010-06-16 | 中国人民解放军军事医学科学院毒物药物研究所 | 吡唑并[4,3-c]喹啉-3-酮化合物、其制备方法及其应用 |
WO2009017954A1 (en) * | 2007-08-01 | 2009-02-05 | Phenomix Corporation | Inhibitors of jak2 kinase |
GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
KR20110031475A (ko) | 2008-06-20 | 2011-03-28 | 제넨테크, 인크. | 트리아졸로피리딘 jak 억제제 화합물 및 방법 |
MX2010014005A (es) * | 2008-06-20 | 2011-02-15 | Genentech Inc | Compuestos de triazolopiridina inhibidores de jak y los metodos. |
CN102317287B (zh) * | 2008-12-19 | 2014-10-08 | 利奥制药有限公司 | 作为磷酸二酯酶抑制剂、用于治疗皮肤病的三唑并吡啶化合物 |
EP2438066A2 (de) | 2009-06-05 | 2012-04-11 | Cephalon, Inc. | Zubereitung und verwendung von 1,2,4-triazol [1,5a]pyridinderivaten |
UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
CN104428300B (zh) * | 2012-07-12 | 2016-11-09 | 奇斯药制品公司 | 酶的抑制 |
WO2014043148A1 (en) * | 2012-09-14 | 2014-03-20 | Dow Agrosciences Llc | An improved process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-amino-2,5-dimethoxypyrimidine |
MA38884A1 (fr) | 2013-09-05 | 2017-06-30 | Hoffmann La Roche | Composé de triazolopyridine, compositions et procédés d'utilisation associés |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE287262C (de) * | ||||
US6355653B1 (en) | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
US6514989B1 (en) * | 2001-07-20 | 2003-02-04 | Hoffmann-La Roche Inc. | Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
-
2002
- 2002-09-18 US US10/246,551 patent/US6693116B2/en not_active Expired - Fee Related
- 2002-09-28 ES ES02777254T patent/ES2269772T3/es not_active Expired - Lifetime
- 2002-09-28 EP EP02777254A patent/EP1436292B1/de not_active Expired - Lifetime
- 2002-09-28 PL PL02370565A patent/PL370565A1/xx not_active Application Discontinuation
- 2002-09-28 AT AT02777254T patent/ATE338043T1/de not_active IP Right Cessation
- 2002-09-28 AU AU2002338827A patent/AU2002338827B2/en not_active Ceased
- 2002-09-28 CN CNB028199138A patent/CN1254475C/zh not_active Expired - Fee Related
- 2002-09-28 JP JP2003534428A patent/JP4101756B2/ja not_active Expired - Fee Related
- 2002-09-28 KR KR1020047005097A patent/KR100604407B1/ko not_active IP Right Cessation
- 2002-09-28 RU RU2004114277/04A patent/RU2298009C2/ru not_active IP Right Cessation
- 2002-09-28 DE DE60214408T patent/DE60214408T2/de not_active Expired - Fee Related
- 2002-09-28 MX MXPA04003278A patent/MXPA04003278A/es active IP Right Grant
- 2002-09-28 WO PCT/EP2002/010917 patent/WO2003031445A1/en active IP Right Grant
- 2002-09-28 BR BR0213177-3A patent/BR0213177A/pt not_active IP Right Cessation
- 2002-09-28 CA CA002462801A patent/CA2462801A1/en not_active Abandoned
- 2002-10-04 AR ARP020103750A patent/AR036735A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR100604407B1 (ko) | 2006-07-25 |
DE60214408D1 (de) | 2006-10-12 |
WO2003031445A1 (en) | 2003-04-17 |
CN1564821A (zh) | 2005-01-12 |
MXPA04003278A (es) | 2004-07-23 |
RU2298009C2 (ru) | 2007-04-27 |
PL370565A1 (en) | 2005-05-30 |
US20030134873A1 (en) | 2003-07-17 |
CN1254475C (zh) | 2006-05-03 |
RU2004114277A (ru) | 2006-01-10 |
US6693116B2 (en) | 2004-02-17 |
AU2002338827B2 (en) | 2007-09-06 |
EP1436292A1 (de) | 2004-07-14 |
AR036735A1 (es) | 2004-09-29 |
KR20040044196A (ko) | 2004-05-27 |
JP4101756B2 (ja) | 2008-06-18 |
ES2269772T3 (es) | 2007-04-01 |
CA2462801A1 (en) | 2003-04-17 |
BR0213177A (pt) | 2004-09-14 |
DE60214408T2 (de) | 2007-03-08 |
EP1436292B1 (de) | 2006-08-30 |
JP2005508954A (ja) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE354570T1 (de) | 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten | |
ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
DE60023167D1 (de) | Pyrazol-derivate als cannabinoidrezeptor-antagonisten | |
DE60216115D1 (de) | BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE | |
ATE328871T1 (de) | 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten | |
ATE293618T1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
ATE288898T1 (de) | Phenylethenyl- oder phenylethinylderivate als glutamatrezeptorantagonisten | |
DE60207241D1 (de) | 5-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidin-derivate | |
DE50210707D1 (de) | Substituierte 2-pyridin-cyclohexan-1,4-diaminderivate | |
PT1381363E (pt) | Derivados de imidazo-(1,2-a)-piridina como antagonistas mglur5 | |
DK1416935T3 (da) | 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater | |
DE60214428D1 (de) | 1, 4-dihydro-1, 4-diphenylpyridin-derivate | |
DE60209251D1 (de) | Adenosine a2a receptor antagonisten | |
ATE360632T1 (de) | Substituierte 8'-pyri(mi)dinyl-dihydrospiro- (cycloalkylamin)-pyrimido(1,2a)pyrimidin-6- onderivate | |
ATE432282T1 (de) | 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten | |
DK1305319T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
DE60133931D1 (de) | Kondensierte purinderivate als a1-adenosinrezeptorantagonisten | |
DE60206652D1 (de) | Benzothiazolderivate als adenosin-rezeptor-liganden | |
PT1360184E (pt) | Derivados de piperidina como antagonistas da neuroquinina 1 | |
DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
ATE338043T1 (de) | 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten | |
MA27094A1 (fr) | Derives triazolo-quinoline utiles en tant que ligands recepteurs d'adenosine. | |
DE50008020D1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
ATE244716T1 (de) | Neue n-triazolylmethyl-piperazinderivate als neurokininrezeptor-antagonisten | |
DE60106974D1 (de) | Aminotriazolopyridinderivate als adenosinrezeptorliganden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1436292 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |